AxoGen (AXGN) Tops Q3 EPS by 7c

AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.45 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Pfizer lung cancer drug misses survival goal in Phase 3 trial